ArticleInvestigative ophthalmology & visual science2025
Proteomic Analysis Provides Insights Into PPIP5K2 Function and Its Impact on Corneal Energy Metabolism.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Purpose: Variants in the Diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) gene may contribute to familial keratoconus (KC) pathogenesis, although the underlying molecular mechanisms remain elusive. We aimed to determine the proteomic effect of PPIP5K2 loss-of-function in response to two KC-related factors (cyclic mechanical stretch [CMS] and TGFβ1 treatment) in primary human corneal fibroblasts (HCFs). Methods: PPIP5K2 knockdown HCFs (n = 4) were cultured and treated with 0, 5, and 10 ng/mL of TGFβ1 with or without 15% CMS (1 cycle/second, 24 hours) using a Flexcell Tension system. Cellular proteins (50 µg) were digested with trypsin and analyzed through label-free liquid chromatography-mass spectrometry. Differentially expressed proteins (DEPs) were determined using 2-way ANOVA by adjusting the effect of TGFβ1 and CMS with false discovery rate (FDR)-adjusted P values ≤ 0.1. Gene ontology (GO) and pathway analyses were performed with the PANTHER classification system. Metabolic profiles of the PPIP5K2 knockdown in HCFs were evaluated with Seahorse assays. Results: A total of 1549 proteins were identified across 48 samples. With FDR ≤ 0.1, the effect of PPIP5K2, TGFβ1 treatment, and CMS status revealed 19 DEPs in the PPIP5K2 knockdown HCFs. GO and pathway analyses revealed over-representation of proteins involved in energy metabolism pathways. Furthermore, a reduction in ATP levels was observed, corroborated by diminished glycolytic function following the loss of PPIP5K2 in HCFs. Conclusions: This study identified many proteins and energy-related pathways following the loss of PPIP5K2 in HCFs, suggesting a potential role of PPIP5K2 in regulating glycolysis in the cornea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.